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Abstract
The NF-kB pathway is regulated by multiple post-translational modifications including phosphorylation, ubiquitylation and
SUMOylation. Many of these modifications act on the natural inhibitor IkBa modulating its capacity to control signal-
mediated NF-kB activity. While the canonical pathway involving the phosphorylation and polyubiquitylation of IkBa has
been well characterized, the role of these post-translational modifications in the control of basal NF-kB activity has not been
deeply explored. Using the recently developed Tandem-repeated Ubiquitin Binding Entities (also known as ubiquitin traps)
to capture ubiquitylated proteins, we identified monoubiquitylated forms of IkBa from multiple rat organs and cell types.
The identification of these forms was demonstrated through different procedures such as immunoprecipitations with
specific ubiquitin antibodies or His6-Ubiquitin pull downs. Monoubiquitylated forms of IkBa are resistant to TNFa-mediated
degradation and can be captured using TUBEs, even after proteasome inhibitors treatment. As it occurs for
monoSUMOylation, monoubiquitylation is not dependent of the phosphorylation of IkBa on the serines 32/36 and is
not optimally degraded after TNFa stimulation. A ubiquitin-IkBa fusion exhibits phosphorylation defects and resistance to
TNFa mediated degradation similar to the ones observed for endogenous monoubiquitylated IkBa. The N-terminal
attachment of a single ubiquitin moiety on the IkBa fusion results in a deficient binding to the IKKb kinase and recruitment
of the SCF ligase component bTrCP, promoting a negative impact on the NF-kB activity. Altogether, our results suggest the
existence of a reservoir of monoubiquitylated IkBa resistant to TNFa-induced proteolysis, which is able to interact and
repress DNA binding and NF-kB transcriptional activity. Such pool of IkBa may play an important role in the control of basal
and signal-mediated NF-kB activity.
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Introduction
The nuclear factor kB (NF-kB) is a family of transcription
factors that regulate the expression of various genes involved in
inflammatory, anti-apoptotic and immune responses [1] [2]. The
NF-kB pathway can be activated by many different extra cellular
signals that induce multiple post-translational modifications such
as phosphorylation, ubiquitylation and SUMOylation, acting at
various levels of the signaling cascade [3–5]. As many other
stimuli, the pro-inflammatory cytokine TNFa (tumor necrosis
factor-alpha) ends with the activation of the IKK (IkBa Kinase)
complex, composed by IKKa, IKKb and IKKc/NEMO [6] [7].
IKK phosphorylates the alpha inhibitor of NF-kB, IkBa, on the
serines 32 and 36 and targets it for ubiquitylation at the main
ubiquitylation sites, lysine 21 and 22 by a SCF (Skp, Cullin, F-box)
ubiquitin ligase complex containing the beta-transducin repeat-
containing protein bTrCP) [8] [9]. The presence of the DSGXXS
motif determines the specific interaction of bTrCP with the
phosphorylated Inhibitor of NF-kB alpha (IkBa), which is crucial
for its ubiquitylation and posterior proteasome degradation. In
contrast, the conjugation with the small ubiquitin-like modifier 1
(SUMO-1) is not dependent on the phosphorylation on the serines
32 and 36 of IkBa and has a positive impact on IkBa stability [10].
Ubiquitylation of IkBa is tightly controlled by the action of
unidentified DUBs (de-ubiquitylating enzymes). Released NF-kBi s
then imported to the nucleus where it activates the transcription of
a large number of genes including IkBa and TNF-receptor 2 [11]
[2]. Newly synthesized IkBais imported into the nucleus where it
ends up with NF-kB mediated transcription by detaching it from
DNA promoter sequences and favoring its export to the cytoplasm
[12] [13].
In this study, the use of ubiquitin traps (TUBEs for Tandem-
repeated Ubiquitin Binding Entities) [14] allowed us to identify
monoubiquitylated IkBa from rat organs, as well as from different
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understand the impact that a single ubiquitin moiety can have on
the properties and inhibitory capacity of IkBaThe evidence
presented here suggests the existence of a pool of monoubiquity-
lated IkBa resistant to degradation whose function might play an
important role in the control of basal and signal-induced NF-kB
activity.
Results
Presence of monoubiquitylated IkBa in organs and cell
lines
The recently developed ubiquitin-traps (TUBEs) that specifi-
cally capture ubiquitin and ubiquitylated proteins [14] were
adapted to extract ubiquitylated proteins from rat organs. As
reported, TUBEs capture preferentially polyubiquitin proteins,
however monoubiquitylated proteins can also be captured when
abundantly expressed [14]. Monoubiquitylated IkBa can be easily
detected by Western blot in a mix of total ubiquitylated proteins
purified by TUBEs from liver, heart, brain, muscle, lung and
kidney rat (Figure 1), suggesting a function for this form of IkBa in
normal tissues. Monoubiquitylated IkBa can also be captured
using a similar procedure with multiple cell lines such as HEK293
(Figure 2A), Jurkat (Figure 2B) and HeLa (data not shown). The
identification of the monoubiquitylated IkBa was confirmed using
several protocols including immunoprecipitations with a specific
anti-ubiquitin antibody of the TUBE-captured material. Under
these conditions endogenous and exogenous monoubiquitylated
IkBa can be detected using anti-IkBa, anti HA or anti SV5
antibodies, respectively (Figure 2C). Furthermore, monoubiquity-
lated IkBa can be also detected in cells co-transfected with
plasmids encoding histidinylated versions of ubiquitin with or
without vectors expressing IkBa WT to purify exogenous and
endogenous ubiquitylated IkBa respectively (Figure 2D). Mono-
ubiquitylated IkBa can also be easily reproduced in vitro using an
ubiquitin mutant (Ub KO) where all reactive lysine residues have
been changed to arginine (Figure 2E). However, monoubiquity-
lated IkBa cannot be immunoprecipitated with monoclonal or
polyclonal IkBa antibodies, alone or combined in a TUBEs-IkBa
immunoprecipitation procedure (Figure S1 and S2). Under these
conditions monoubiquitylated IkBa is detected in the unbound
fraction. Thus, the monoubiquitylated form of IkBa, found in
organs and cell lines, shows a poor accessibility to IkBa
immunoprecipitation but can be detected using denaturing gels
followed by Western blot analysis.
Monoubiquitylated IkBa is not sensitive to the TNFa-
mediated degradation
To evaluate the susceptibility of the monoubiquitylated form of
IkBa to be degraded by TNFa a TUBE-capture assay was
performed in HEK293 cells treated or not with proteasome
inhibitor MG132 (Figure 3). As expected, most IkBa is degraded
after 20 minutes of TNFa-stimulation as it can be seen in the input
(IN). This proteolytical process is blocked in the presence of
MG132 where IkBa is accumulated as hyperphosphorylated form.
The analysis of the TUBE-captured material shows that mono-
ubiquitylated IkBa remain very stable after 20 or 60 minutes of
TNFa stimulation even in the presence of proteasome inhibitor
(Figure 3A). Interestingly, the capacity of the TUBE-hHR23 to
capture monoubiquitylated and polyubiquitylated forms of IkBa is
not compromised when the proteasome activity is inhibited. These
results suggest that the monoubiquitylated form of IkBa is not
destabilized by the induction with TNFa but it is slightly
accumulated after treatment with MG132 (Figure 3A). To
evaluate the role of the serines 32/36 phosphorylation on the
accumulation of monoubiquitylated form of IkBa, a mutant S32/
36A was transfected into HEK293 cells. In the absence of TNFa
stimulation and MG132, modified forms of IkBa were captured
Figure 1. Extraction of monoubiquitylated IkBa from rat organs. Extraction of total ubiquitylated proteins from liver, brain, heart, muscle,
lung and kidney [14]. TUBEs (T) or GST control (C) bound proteins were analyzed by Western blot with the anti-ubiquitin and anti-IkBa antibodies.
Membranes were stained with Ponceau, used as charge control, (1) TUBEs; 2) GST). Input (IN), Flow through (FT).
doi:10.1371/journal.pone.0025397.g001
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nickel beads chromatography. Our results confirm that the
monoubiquitylation of IkBa is not dependent of the phosphory-
lation of serines 32 and 36 (Figure 3B). MonoSUMOylation with
SUMO-2 and SUMO-1 (only visible on long exposures, data not
shown) are also independent of this signaling pathway. In contrast,
high molecular weight forms can not be seen on the S32/36A
IkBa mutant after TNFa stimulation in a situation where
polyubiquitylated IkBa WT is well accumulated (Figure 3B).
Extended half-life of monoubiquitylated IkBa
The analysis of a subpopulation of IkBa molecules and in
particular its impact on NF-kB activity is difficult to achieve if
mixed populations of IkBa molecules are present. There is no
available method of purification able to isolate unmodified or
ubiquitylated IkBa molecules with homogeneous characteristics.
For this reason, to further understand the role of monoubiquity-
lated form of IkBa, an ubiquitin-IkBa fusion protein was
generated (Figure 4A). This approach has been largely used as it
can be judged in the literature especially to study the role of
ubiquitin and ubiquitin-like proteins in the regulation of protein
localization and function [15]. The ubiquitin-IkBa fusion has been
optimized to resist to the action of DUBs by introducing, at the C-
terminal of ubiquitin, a double alanine (AA) instead of the double
glycine (GG). To avoid additional attachment of moieties at the N-
terminus of IkBa, lysine 21 and 22 were mutated to alanine (KK
to AA). Attachment of ubiquitin at a single N-terminus lysine
acceptor of IkBa provide similar stability effects [16,17].
Ubiquitin-IkBa fusion protein shows similar sub-cellular distribu-
tion than IkBa WT (Figure S3). When expressed in HEK293 and
HeLa cells, ubiquitin-IkBa fusion protein showed an extended
half-life compared to IkBa WT (Figure 4B and data not shown).
The effect of a single ubiquitin moiety on IkBa stability is also
reflected after signal-mediated stimulation, as this ubiquitin-IkBa
fusion shows resistance to TNFa induced degradation (Figure 4C).
A kinetic of degradation was performed to confirm that the
observed resistance was not due to a delay in TNFa-induced IkBa
degradation (Figure 4D). Proteolytical defects are not due to the
Figure 2. Isolation of monoubiquitylated IkBa from cell lines and in vitro. A, B) TUBE-based isolation and detection of monoubiquitylated
IkBa from HEK293 cells (A) and Jurkat cells (B) treated or not 1 h with 20 mM of MG132. Input (IN), Flow through (FT). C) HEK293 cells were transfected
with the indicated constructs before being lysed in a buffer containing 3.5 mM of TUBE hHR23A. TUBE-captured material was eluted and submitted
to Ubiquitin immunoprecipitation. EV: Empty Vector. D) Nickel chromatography was used to isolate His6-Ubiquitin conjugates from HEK293 cells co-
transfected (+) or not (2) with a vector expressing IkBa and His6-Ubiquitin or Empty vector (EV). E) In vitro ubiquitylation assay in presence of
ubiquitin mutant (Ub KO) using
35SI kBa WT as substrate.
doi:10.1371/journal.pone.0025397.g002
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ubiquitin-IkBa fusions provides similar results (data not shown).
Furthermore, these effects appear to be specific of ubiquitin, as
fusions containing other molecules from the ubiquitin family do
not provide the same results (data not shown). Thus, from these
results we conclude that the attachment of a single ubiquitin
moiety extends the half-life of the ubiquitin-IkBa fusion and
perfectly reproduce the stability after TNFa-stimulation observed
with the endogenous monoubiquitylated form of IkBa.
Phosphorylation defects of monoubiquitylated IkBa
In order to understand the molecular origin of ubiquitin-IkBa
fusion stability, its capacity to be phosphorylated after TNFa
stimulation was investigated. We could observe a reproducible
reduction of ubiquitin-IkBa fusion phosphorylation when com-
pared to IkBa WT (Figure 5A). This is mainly due to the incapacity
of ubiquitin-IkBa fusion protein to efficiently bind IKKb compared
to IkBa WT in TNFa-stimulated HEK293 cells (Figure 5B).
Experimental data demonstrate that the exogenously expressed
Figure 3. Monoubiquitylated IkBa is not sensitive to TNFa-mediated degradation. A) HEK293 cells were pre-treated or not 1 h with 20 mM
of MG132 and stimulated with TNFa (10 ng/ml) for the indicated times. Cells were lysed in a buffer containing TUBE-hHR23A and bound proteins
were analyzed by Western blot with the anti-IkBa antibody. B) HEK293 cells were transfected with the indicated plasmids, pre-treated or not 1 h with
20 mM MG132 and stimulated with TNFa (10 ng/ml). His6-ubiquitylated or SUMOylated proteins were purified using denaturing conditions and Ni
2+
chromatography procedure. The SUMOylated form of IkBa is indicated by an *. EV: Empty vector.
doi:10.1371/journal.pone.0025397.g003
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compared to IkBa WT under the same experimental conditions.
Altogether our results clearly indicatethat ubiquitin-IkBa fusion but
notIkBa WTshowsdefectsinthe interactionwith criticalmolecules
of the signaling pathway including IKKb and bTrCP, thus
explaining at least in part, its resistance to proteolysis (Figure 5B).
Figure 4. Stability of ubiquitin-IkBa fusion protein. A) Ubiquitin-IkBa fusion was generated with an N-terminal HA and C-terminal V5 epitopes.
B) HEK293 cells transfected with IkBa WT and ubiquitin-IkBa fusion were treated with 50 mg/ml CHX for the indicated times. The graph corresponds
to the mean of three independent experiments. C) IkBa WT and ubiquitin-IkBa fusion were expressed in HEK293 and stimulated for 20 minutes with
10 ng/ml of TNFa.D )I kBa WT and ubiquitin- IkBa fusionwere expressed in HEK293 cells and stimulated with 10 ng/ml of TNFa for the indicated
times.
doi:10.1371/journal.pone.0025397.g004
Figure 5. Phosphorylation defect of ubiquitin-IkBa fusion. A) IkBa WT and ubiquitin-IkBa fusion were expressed in HEK293 cells and
pretreated or not with 20 mM of MG132 for 1 hour before being stimulated with 10 ng/ml of TNFa for 20 minutes. Sam68 was used as a charge
control B) Ubiquitin-IkBa fusion deficiently binds endogenous IKKb kinase and the bTrCP. IkBa WT and ubiquitin-IkBa fusion were expressed in
HEK293 cells, pretreated or not with 20 mM of MG132 for 1 hour and stimulated with 10 ng/ml of TNFa for 20 minutes. Cell lysates were
immunoprecipitated with HA antibody and analyzed by Western-blot using indicated antibodies.
doi:10.1371/journal.pone.0025397.g005
Monoubiquitylation of the NF-kB Inhibitor IkBa
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To investigate the effect of ubiquitin-IkBa fusion on the NF-kB
activity, first we explored its capacity to bind NF-kB and to inhibit
NF-kB/DNA binding. Interaction with the NF-kB subunit p65
was tested in HEK293 cells expressing or not exogenous p65 and
ubiquitin-IkBa or IkBa WT as indicated in Figure 6A. Our results
clearly indicate that p65 co-immunoprecipitates equally well with
both ubiquitin-IkBa and IkBa WT. To explore the capacity of
ubiquitin-IkBa fusion to inhibit NF-kB/DNA binding, electropho-
retic mobility shift assay (EMSA) were performed using increasing
Figure 6. Ubiquitin-IkBa fusion negatively affects TNF-induced NF-kB activity. A) Ubiquitin-IkBa fusion protein has the same capacity as
unmodified IkBa to bind to NF-kB. HEK293 cells were transfected with the indicated plasmids. Lysates were submitted to anti-HA
immunoprecipitation and Western blotted with the indicated antibodies B) Ubiquitin-IkBa fusion protein inhibits NF-kB/DNA binding as well as
unmodified IkBa. Different amount of recombinant IkBa fusions proteins (1: 0,05 ml, 2: 0,1 ml and 3: 0,5 ml) and p65 were incubated with a radioactive
labeled NF-kB probe for EMSA studies [12]. Comp.: competition with a 100-fold excess of the same unlabeled oligonucleotide added to the binding
assay before the
32P-labeled probe. The graph corresponds to the mean of three independent experiments. C) IkBa KO fibroblasts were co-
transfected with IkBa WT or ubiquitin- IkBa fusion expressing plasmid and a NF-kB-luciferase reporter (3 EnhConA-Luc). Luciferase activity was
measured as previously described [17]. The graph corresponds to the mean of three independent experiments.
doi:10.1371/journal.pone.0025397.g006
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in Figure 6B, the capacity of ubiquitin-IkBa fusion to inhibit NF-
kB/DNA interaction is similar to the one of IkBa WT. To further
explore the effect of ubiquitin-IkBa on the NF-kB activity after
TNFa stimulation, luciferase reporter assays were set up. To avoid
interferences with endogenous IkBa MEF coming from IkBa KO
mice were employed. The inhibitory effect of ubiquitin-IkBa fusion
became statistically significant after 6 hours of TNFa stimulation
(Figure 6C). Thus, our results indicate that in the presence of
ubiquitin-IkBa fusion, activation of NF-kB is negatively regulated
after TNFa stimulation. Altogether, our results suggest the existence
of distinct populations of IkBa molecules among which mono-
ubiquitylated IkBa offers resistance to TNFa mediated degradation
preserving a dormant pool of NF-kB that is different to the one
activated through the activation of this signaling pathway (Figure 7).
Discussion
While polyubiquitylation of proteins has been associated to the
regulation of signaling cascades or protein degradation by the
Ubiquitin Proteasome System, monoubiquitylation or multiple
monoubiquitylation have diverse non-catabolic functions [18].
Major technical problems to separate the ubiquitylated pool of
endogenous proteins from unmodified ones justify our limited
knowledge of the post-modification events. The broad distribution
of monoubiquitylated IkBa in multiple organs and cell lines
underlines the in vivo importance of this pool of IkBa. Endogenous
monoubiquitylated IkBa is stable after TNFa stimulation and does
coexist with polyubiquitylated IkBa under the same conditions.
Therefore monoubiquitylated IkBa does not appear to be a
precursor of polyubiquitylated forms of this inhibitor molecule,
although a dynamic equilibrium between these populations cannot
be excluded. Monoubiquitylated IkBa accumulated after protea-
some inhibitor and TNFa treatment can be the result of
proofreading mechanism acting on polyubiquitylated IkBa. With
the help of a DUB-resistant ubiquitin-IkBa fusion, results
presented here show that monoubiquitylated IkBa has an impact
on basal and TNFa-induced NF-kB transcription. It remains to be
investigated the nature of the stimuli (if any) able to drive an
efficient proteolysis of monoubiquitylated IkBa. In a similar way
SUMO-1 was reported to regulate IkBa stability and NF-kB
transcription [10]. However it is unclear if both IkBa pools
Figure 7. Integrated view of the time-dependent contribution of monoubiquitylated versus non-modified form of IkBa in the
control of its proteasomal degradation and regulation of NF-kB activity.
doi:10.1371/journal.pone.0025397.g007
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mediated turnover. Several lines of evidence suggest that
monoubiquitylated IkBa might adopt a structured/protected
conformation. The first evidence is the difficulty to pull down
endogenous monoubiquitylated IkBa with various monoclonal
and polyclonal antibodies. Second, the ubiquitin-IkBa fusion is
not efficiently recognized by the IKKb subunit resulting in a
limited phosphorylation and binding to bTrCP. Finally, the
impact of the fused ubiquitin on the IkBa resistance to TNFa-
induced proteolysis, suggest reduced capacity to interact/get
access to the proteasome. Attachment of monoubiquitin onto
IkBa perhaps occludes IKK binding sites or creates molecular
interference with this kinase. Under these circumstances, bTrCP
might have difficulties to polyubiquitylate poorly phosphorylated
IkBa. The unstructured extremities of IkBa favor the ubiquitin-
independent proteasomal degradation of this molecule [19]
justifying the necessity to generate a stable pool of monoubiqui-
tylated IkBa. If there is an ubiquitin-protein ligase different than
the SCF-bTrCP complex, it has to be proven. However, one has
to keep in mind that E3-independent monoubiquitylation has been
reported for proteins containing ubiquitin-binding domains [20].
Recently, monoubiquitylation of Rpn10 subunit of the proteasome
has been shown to adopt a closed conformation due to the intra-
molecular interaction with its ubiquitin interacting motif or UIM
[21]. In the case of Rpn10, monoubiquitylation affects presenta-
tion of ubiquitylated proteins to the proteasome. However, if this
occluding mechanism exists for monoubiquitylated IkBa there is
no evidence of an ubiquitin-binding domain present on this
inhibitor. Nonetheless, the active molecular dynamics reported for
the NF-kB system even under basal conditions [22] [23] [24]
justifies the existence of monoubiquitylated IkBa as a cellular
reservoir to regulate basal as well as signal-mediated NF-kB
activity. Knowing the resistance to proteolysis observed for
monoubiquitylated IkBa, one can speculate that an artificial
increase of this pool could let to a better control of immune and/or
pro-inflammatory responses found in organisms that have been
exposed to multiple and/or sequential stimuli activating NF-kB.
Future work will elucidate the role of the different populations of
IkBa in the optimal control of this critical transcription factor.
Materials and Methods
Animals
Ethics Statement. Experiments were approved by the
respective institutional committees for animal care and handling.
Adult male Sprague–Dawley rats were deeply anesthetized with
chloral hydrate and some tissues and organs were extracted. These
samples were washed with cold PBS, immediately frozen in liquid
nitrogen and stored at 280uC.
Cell cultures
HEK293 and HeLa (ATCC) were grown in DMEM (Gibco);
Jurkat cells (ATCC) in RPMI (Gibco), all supplemented with 10%
FBS and antibiotics. HEK293 and HeLa were transfected using
lipofectamine (Invitrogen). For measurement of transcriptional
activity, MEF null IkBa (kindly given by David Baltimore) were
co-transfected with a NF-kB-luciferase reporter plasmid (3-
EnhConA) and plasmids expressing IkBa WT or the ubiquitin-
IkBa fusion. Luciferase activity was measured as previously
described [17]. To analyze the half-life of the different proteins,
cells were treated with 50 mg/ml of cycloheximide (Sigma) during
the indicated times. For stability experiments, cells were treated for
1 hour with 20 mM of MG132 (Calbiochem), stimulated for
30 minutes or the indicated times with 10 ng/ml of TNFa(R&D
Systems). P65, IKKb and bTrCP co-immunoprecipitation exper-
iments were performed using Protein-G cross-linked with the HA
antibody to immunoprecipitate exogenous IkBa WT or ubiquitin-
IkBa fusion protein. In all cases, cells were lysed for 15 minutes on
ice in 50 mM sodium fluoride, 5 mM tetra-sodium pyrophos-
phate, 10 mM beta-glyceropyrophosphate, 1% Igepal CA-630,
2 mM EDTA, 20 mM Na2HPO4, 20 mM NaH2PO4,1 m M
Pefablock, 1.2 mg/ml Complete protease inhibitor cocktail
(Roche).
PCR and cloning
Ubiquitin gene (accession numbers CAA44911) was used to
generate IkBa fusion and cloned into BamHI/Not1 restriction
sites of pCDNA3. The C-terminal glycine residues (GG) of
ubiquitin were changed to alanine (AA) and lysine 21 and 22 of
IkBa were mutated to alanine to avoid respectively the action of
DUBs and additional attachment of moieties at the N-terminus of
IkBa, using the following oligonucleotides: 59-ctc cgt ctt aga gct
gcg gag cgg cta ctg gac gac-39 and 59-gtc gtc cag tag ccg ctc cgc
agc tct aag acg gag-39. His6-Ubiquitin construct has been
previously reported [13].
Purification of ubiquitylated proteins
Frozen tissues were triturated in liquid nitrogen and recovered
in the previously reported lysis buffers [14], containing 200 mgo f
TUBEs-HR23A (T) (Life Sensors) or Glutathione S-transferase
(GST) (C). Lysates were clarified by cold centrifugation, and added
to glutathione agarose beads (Sigma). Glutathione beads were
eluted and bound material was submitted to Western-blot analysis
or to IkBa (Cell Signaling) and ubiquitin (FK2, ENZO)
immunoprecipitations. His6-ubiquitylated proteins were purified
using denaturing conditions and Ni
2+ chromatography as
previously described [13].
Western blotting
Immunodetections were performed with the following primary
antibodies: mouse monoclonals SV5 (Serotec); HA (Covance);
Ubiquitin P4D1 (Santa Cruz Biotechnology Inc), FK2 (ENZO);
IkBa (Cell Signaling), IkBa 10B (kindly provided by RT Hay) and
anti-phospho-IkBa (Cell Signaling) antibodies; rabbit polyclonals
IkBa (C21) (Santa Cruz Biotechnology); p65 (Santa Cruz
Biotechnology); IKKb (Cell Signaling) and Sam68 (Santa Cruz
Biotechnology) antibodies and goat polyclonal antibody bTrCP
(Santa Cruz Biotechnology).
In vitro ubiquitylation assays
In vitro transcribed/translated IkBa (
35S-Met-labelled or not
when indicated) were incubated in a 15 ml reaction including an
ATP regenerating system [25 mM Tris pH 7.5, 5 mM MgCl2,
2 mM ATP, 10 mM creatine phosphate (Sigma), 5 mM NaCl2,
3.5 U/ml of creatine kinase (Sigma) and 0.6 U/ml of inorganic
pyrophosphatase (Sigma)], 10 mg of ubiquitin mutant (Ub KO)
where all reactive lysine residues have been changed to arginine
ubiquitin, 10 ng human E1 (Biomol), 500 ng UbcH5b (Biomol).
After incubation at 30uC for 120 min the reaction was stopped
with SDS Laemmli buffer containing b-mercaptoethanol, samples
were fractionated by SDS-PAGE and the dried gels analysed by
phosphorimaging.
Electrophoretic Mobility Shift Assays (EMSA)
Reactions were prepared in binding buffer containing 25 mM
HEPES, 1 mM EDTA, 3.5 mM spermidine, 6 mM MgCl2,
100 mM NaCl, 0.15% Nonidet P-40, 10% glycerol, 10 mM
Monoubiquitylation of the NF-kB Inhibitor IkBa
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dAT/dGC, different amount of IkBa fusion proteins (1: 0,05 ml, 2:
0,1 ml and 3: 0,5 ml) and recombinant protein p65 and incubated
at room temperature for 20 minutes. Finally, 10000 cpm of
32P-
radiolabelled (polynucleotide kinase, Biolabs) double strand
oligonucleotide probe containing the NF-kB binding site motif
from the HIV type 1 enhancer (59-CTA GAC GGG GAT TTC
CGA GAG GT-39) was added and the mixture was incubated at
room temperature for 20 minutes. After electrophoresis, gels were
dried and exposed to Amersham Hyperfilm MP at 270?C.
Specific binding was checked by competition with a 100-fold
excess of the same unlabeled oligonucleotide added to the binding
assay before the
32P-labeled probe.
Supporting Information
Figure S1 Immunoprecipitation using IkBa antibodies fail to
pull down monoubiquitylated IkBa. HEK293 cells were treated or
not for 1 hour with 20 mM of MG-132, lysed in the properly lysis
buffer for 20 minutes, centrifuged and the supernatant was
incubated with cross-linked anti- IkBa (10B) antibody for 2 hours.
After incubation the samples were centrifuged, washed and
prepared for Western blot analysis using IkBa antibody (Cell
Signaling).
(TIF)
Figure S2 TUBE-captured monoubiquitylated IkBa fails to be
immunoprecipitated using specific IkBa antibodies. HEK293 cells
were treated or not, 1 hour with 20 mM of MG-132 and lysed in a
buffer containing 100 mg of TUBE-HR23A or GST proteins.
After lysis, samples were centrifuged and clarified supernatant
incubated for 2 hours in the presence of glutathione agarose
beads. Eluted samples were incubated for 2 hours with protein A
cross-linked antibody anti-IkBa 10B or anti-IkBa C21 antibody
(not shown). After incubation, samples were washed and prepared
for Western blot analysis using IkBa antibody (Cell Signaling).
(TIF)
Figure S3 IkBaWT and ubiquitin-IkBa fusion were expressed
in HEK293 cells, and processed for immunostaining with anti-
SV5 or anti-HA antibodies.
(TIF)
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